United States Skin Cancer Market to Surpass US$ 20 Billion by 2033, Exhibiting a 7.6% CAGR | Top Companies are Merck & Co., Inc., Amgen, Inc., Pfizer Inc., Genentech USA, Inc.

The global skin cancer market size reached US$ 10.61 Billion in 2024 from US$ 9.92 Billion in 2023 and is expected to reach US$ 20.48 Billion by 2033, growing at a CAGR of 7.6% during the forecast period 2025-2033.

The Skin Cancer Market encompasses treatments for melanoma and non-melanoma cancers caused by UV radiation exposure. Growth is driven by early detection methods, immunotherapies, and targeted drugs. Hospitals, cancer centers, and research institutes are primary end-users. Innovations include personalized oncology and AI-based diagnostic imaging. Increasing awareness and government initiatives for skin protection boost adoption. Rising incidence rates globally continue to propel market demand.

📌 Download Sample Report to Identify Emerging Deals & Opportunities in the Skin Cancer Market Landscape:- https://datamintelligence.com/download-sample/skin-cancer-market?Ranjith

☛ Skin Cancer Market Recent Developments 2025:

United States: Recent Industry Developments

✅ In September 2025, Pfizer Inc. announced positive results from its Phase 3 trial of PF-07901764, a next-generation BRAF/MEK inhibitor combination for advanced melanoma. The therapy demonstrated improved progression-free survival compared to current standards.

✅ In August 2025, Merck & Co., Inc. received FDA approval for Keytruda® (pembrolizumab) in combination with Lenvima® for treating unresectable cutaneous squamous cell carcinoma (cSCC). This marks a significant step in expanding immunotherapy options for non-melanoma skin cancers.

✅ In July 2025, Bristol Myers Squibb (BMS) initiated a Phase 2 clinical study investigating the efficacy of nivolumab + relatlimab combination therapy in early-stage melanoma to prevent recurrence after surgical removal.

✅ In May 2025, AbbVie Inc. partnered with DermTech Inc. to advance non-invasive skin genomics testing, integrating RNA analysis with AI algorithms for early skin cancer detection and personalized treatment selection.

Japan: Recent Industry Developments

✅ In September 2025, Chugai Pharmaceutical Co., Ltd. launched a real-world data project in collaboration with National Cancer Center Japan to evaluate the long-term outcomes of immune checkpoint inhibitors in melanoma patients.

✅ In August 2025, Ono Pharmaceutical Co., Ltd. expanded indications of Opdivo® (nivolumab) in Japan for treating advanced basal cell carcinoma (BCC) after local therapy failure, marking a regional milestone in immuno-oncology.

✅ In July 2025, Kyowa Kirin Co., Ltd. developed a novel photodynamic therapy (PDT) system combining nanocarrier drug delivery with precision laser activation for superficial skin cancers.

✅ In June 2025, Shiseido Co., Ltd. announced research collaboration with Keio University to identify UV-induced DNA repair biomarkers that could support early diagnosis and prevention strategies for skin cancer.

☛ Skin Cancer Market Competitive Landscape:

Merck & Co., Inc., Amgen, Inc., Pfizer Inc., Genentech USA, Inc., Regeneron Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Sun Pharmaceutical Industries, Inc., Immunocore Ltd., IOVANCE Biotherapeutics, Inc. and Incyte.

Research Methodology

We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.

📌 Request a Customized Market Report - Tailored insights to match your business goals: https://datamintelligence.com/customize/skin-cancer-market?Ranjith

☛ Segments Covered in the Skin Cancer Market:

By Cancer Type:

Non-Melanoma | Melanoma

By Treatment:
Immunotherapy | Chemotherapy | Photodynamic Therapy | Targeted Therapy | Radiation Therapy | Others

By End-User:
Hospitals | Dermatology Clinics | Academic and Research Institutes | Others

☛ This Report Includes:
✔ Comprehensive go-to-market strategies with actionable insights.

✔ Unbiased evaluation of overall market performance.

✔ Deep-dive analysis into development trends, competitive landscape, supply-demand dynamics, YoY growth, benchmarking, vendor mapping, market access, and overall progress.

✔ Tailored regional and country-level reports with detailed localized analysis available on request.

✔ Identification of niche segments and high-growth regions presenting strong opportunities.

✔ Accurate regional forecasts using both top-down and bottom-up approaches.

📌 Get Corporate Access to Live Skin Cancer Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=skin-cancer-market?Ranjith

☛ Regional Analysis for Skin Cancer Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription

☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.